The Pathology Core plays a supportive role in the grant by providing anatomic and hematopathology data. The group has four research activities involving: 1) graft-versus-host disease (GVHD), 2) interstitial pneumonia, 3) veno-occlusive disease, and 4) viral diagnostic histology. These activities deal with important problems in the pathogenesis of, and methodology for improving the diagnosis and treatment of the diseases of bone marrow transplantation. Activity 1 tests the stem cell hypothesis of GVHD targeting as a way of gaining new insights into the pathogenesis of GVHD at the effector level.
Its aims are to provide better predictive value specificity and sensitivity tests for GVHD and improve the distinction between pseudo-GVHD occurring in syngeneic and autologous patients and true GVHD. This includes a method of predicting early GVHD before day 21. Activity 2 addresses a new distinction within the noninfectious pneumonia group and deals with bronchoalveolar lavage detection methods for these conditions. It predicts different pathogenesis for diffuse alveolar damage and interstitial pneumonia and implies different therapies. Activity 3 proposes a new way to predict the risk of veno-occlusive disease of the liver based on immunohistological study of liver biopsies in transplant patients with and without prior liver inflammation. Activity 4 deals with improved viral diagnosis by 1) polymerase chain reaction detection of early cytomegalovirus pneumonia in bronchoalveolar lavage specimens, 2) the study of viral latency by detecting the genes for early antigens as signals for activation of latent disease, 3) the development of new single-stranded probes for improved viral diagnosis, 4) development of multiple in situ hybridization screening panel for four viruses (cytomegalovirus, HSV-1, HSV-2 and VZV) using pcr probes, and 5) improved Y chromosome in situ hybridization detection by the use of combined Y and X chromosome probes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA018029-18
Application #
3771409
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
McCune, Jeannine S; Storer, Barry; Thomas, Sushma et al. (2018) Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients. Biol Blood Marrow Transplant 24:1802-1807
Deegan, Anthony J; Talebi-Liasi, Faezeh; Song, Shaozhen et al. (2018) Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions. Lasers Surg Med 50:183-193
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515
Schmitt, Michael W; Pritchard, Justin R; Leighow, Scott M et al. (2018) Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias. Clin Cancer Res 24:5321-5334
Shaw, Bronwen E; Syrjala, Karen L; Onstad, Lynn E et al. (2018) PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. Cancer 124:841-849
Jamani, Kareem; Onstad, Lynn E; Bar, Merav et al. (2018) Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2271-2276
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Salter, Alexander I; Pont, Margot J; Riddell, Stanley R (2018) Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131:2621-2629
Lee, Stephanie J; Nguyen, Tam D; Onstad, Lynn et al. (2018) Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:555-562
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313

Showing the most recent 10 out of 1845 publications